↓ Skip to main content

Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD): a randomised controlled trial (BICS)

Overview of attention for article published in Trials, April 2022
Altmetric Badge

Mentioned by

twitter
2 X users

Readers on

mendeley
52 Mendeley